<code id='F577E214F7'></code><style id='F577E214F7'></style>
    • <acronym id='F577E214F7'></acronym>
      <center id='F577E214F7'><center id='F577E214F7'><tfoot id='F577E214F7'></tfoot></center><abbr id='F577E214F7'><dir id='F577E214F7'><tfoot id='F577E214F7'></tfoot><noframes id='F577E214F7'>

    • <optgroup id='F577E214F7'><strike id='F577E214F7'><sup id='F577E214F7'></sup></strike><code id='F577E214F7'></code></optgroup>
        1. <b id='F577E214F7'><label id='F577E214F7'><select id='F577E214F7'><dt id='F577E214F7'><span id='F577E214F7'></span></dt></select></label></b><u id='F577E214F7'></u>
          <i id='F577E214F7'><strike id='F577E214F7'><tt id='F577E214F7'><pre id='F577E214F7'></pre></tt></strike></i>

          Wikipedia

          Wikipedia

          author:Wikipedia    Page View:2116
          Stock photo of a heart monitor function on an apple watch
          Adobe

          As wearable health devices grow more popular in the U.S., there’s a growing opportunity to track the broader adult population’s heart health. But it’s much harder for an Apple Watch to accurately detect the heart’s electrical signals and rhythm than a set of hospital-grade electrodes. Its readings are messier, often because of poor contact with the skin.

          A team of Yale researchers published a paper in Nature this month exploring a potential solution: an artificial intelligence algorithm trained on noisy electrocardiograms, electrical pulse recordings that illustrate heart function. Starting an algorithm off with this data could help it more easily adapt to the reality of imperfect wearable sensors.

          advertisement

          “You could say I’m going to find the clean, pristine-looking ECG that looks a lot more like the ECG done in a clinical setting, and only use those for diagnostics,” said study author Rohan Khera, a cardiologist and data scientist at Yale. “But that’s not the reality. Clinical ECGs are not obtained on wristwatches.”

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          explore

          FDA approval of Sarepta Duchenne genetic therapy gives me hope
          FDA approval of Sarepta Duchenne genetic therapy gives me hope

          Duchennemusculardystrophyhistopathology.Dr.EdwinP.Ewing,Jr./CDCWhenIwasdiagnosedwithDuchennemuscular

          read more
          BioAge raises $170M for combination therapy with Zepbound
          BioAge raises $170M for combination therapy with Zepbound

          Illustration:STAT;Source:EliLilly/APACaliforniabiotechdevelopingacombinationtherapywiththeobesitydru

          read more
          Medical records are filled with copy
          Medical records are filled with copy

          AdobeIrecentlytookcareofapatientwhosemedicalrecordsincludedmultiplenotesaboutherpastopen-heartsurger

          read more

          Gilead might be held responsible for not developing a drug

          JustinSullivan/GettyImagesTheassaultonthedevelopmentofnewlifesavingtherapiescontinuesapace.Recently,